Das Angioödem in der Notaufnahme

Moellman JJ, Bernstein JA, Lindsell C, Banerji A, Busse PJ, Camargo CA et al (2014) A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med 21(4):469–484 LoVerde D, Files DC, Krishnaswamy G (2017) Angioedema. Crit Care Med 45(4):725–735 Ring J, Beyer K, Biedermann T, Bircher A, Fischer M, Fuchs T et al (2021) Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update. Allergo J Int 30(1):1–25 Bork K (2014) Angioedema. Immunol Allergy Clin North Am 34(1):23–31 Bork K, Meng G, Staubach P, Hardt J (2006) Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 119(3):267–274 Pappalardo E, Caccia S, Suffritti C, Tordai A, Zingale LC, Cicardi M (2008) Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: Functional and structural correlates. Mol Immunol 45(13):3536–3544 Craig T, Pürsün EA, Bork K, Bowen T, Boysen H, Farkas H et al (2012) WAO guideline for the management of hereditary angioedema. World Allergy Organ J 5(12):182–199 Aygören-Pürsün E, Magerl M, Maetzel A, Maurer M (2018) Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies. Orphanet J Rare Dis 13(1):73 Farkas H, Martinez-Saguer I, Bork K, Bowen T, Craig T, Frank M et al (2017) International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy 72(2):300–313 Bork K, Staubach P, Eckardt AJ, Hardt J (2006) Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 101(3):619–627 Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, Baker J et al (2010) Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 363(6):513–522 Lumry WR, Li HH, Levy RJ, Potter PC, Farkas H, Moldovan D et al (2011) Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST‑3 trial. Ann Allergy Asthma Immunol 107(6):529–537 Prematta M, Gibbs JG, Pratt EL, Stoughton TR, Craig TJ (2007) Fresh frozen plasma for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 98(4):383–388 Baş M, Greve J, Stelter K, Havel M, Strassen U, Rotter N et al (2015) A randomized trial of Icatibant in ACE-inhibitor–induced angioedema. N Engl J Med 372(5):418–425 Beltrami L, Zingale LC, Carugo S, Cicardi M (2006) Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it. Expert Opin Drug Saf 5(5):643–649 Bas M, Kojda G, Bier H, Hoffmann TK (2004) Durch ACE-Hemmer induziertes Angioödem des Kopf-Hals-Bereichs: Eine Frage der Zeit? HNO 52(10):886–890 Bas M, Greve J, Strassen U, Khosravani F, Hoffmann TK, Kojda G (2015) Angioedema induced by cardiovascular drugs: new players join old friends. Allergy 70(10):1196–1200 Dean DE, Schultz DL, Powers RH (2001) Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 46(5):15129J Banerji A, Oren E, Hesterberg P, Hsu Y, Camargo CA, Wong JT (2008) Ten-year study of causes of moderate to severe angioedema seen by an inpatient allergy/immunology consult service. Allergy Asthma Proc 29(1):88–92 Roe N, Twilla JD, Duhart B, Wheeler B (2017) Breast cancer patient with everolimus-induced angioedema: A rare occurrence with potential for serious consequences. J Oncol Pharm Pract 23(4):318–320 Wadei H, Gruber SA, El-Amm JM, Garnick J, West MS, Granger DK et al (2004) Sirolimus-induced angioedema. Am J Transplant 4(6):1002–1005 Myslimi F, Caparros F, Dequatre-Ponchelle N, Moulin S, Gautier S, Girardie P et al (2016) Orolingual angioedema during or after thrombolysis for cerebral ischemia. Stroke 47(7):1825–1830 Gallais Sérézal I, Bouillet L, Dhôte R, Gayet S, Jeandel PY, Blanchard-Delaunay C et al (2015) Hereditary angioedema and lupus: A French retrospective study and literature review. Autoimmun Rev 14(6):564–568 Shi Y, Wang C (2021) Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review. Clin Immunol 230:108819 Ring J, Beyer K, Biedermann T, Bircher A, Duda D, Fischer J et al (2014) Guideline for acute therapy and management of anaphylaxis. Allergo J Int 23(3):96–112 Bork K, Hardt J, Witzke G (2012) Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 130(3):692–697 Papadopoulou-Alataki E (2010) Upper airway considerations in hereditary angioedema. Curr Opin Allergy Clin Immunol 10(1):20–25 McCormick M, Folbe AJ, Lin HS, Hooten J, Yoo GH, Krouse JH (2011) Site involvement as a predictor of airway intervention in angioedema: Airway intervention in angioedema. Laryngoscope 121(2):262–266 Nzeako UC, Longhurst HJ (2012) Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema. Eur J Gastroenterol Hepatol 24(4):353–361 Borum ML, Ali MA (2014) Hereditary angioedema: what the gastroenterologist needs to know. Clin Exp Gastroenterol. https://doi.org/10.2147/ceg.s50465 Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K et al (2014) Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 69(5):602–616 https://www.hae-online.de/informationsmaterial. Zugegriffen: 10.06.2022 Caballero T et al (2011) Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol 21(5):333–347